Michael Barbella, Managing Editor03.09.24
Robotics ruled ODT's digital realm this past week.
Not surprising, since the technology is a key growth strategy among top orthopedic implant manufacturers. However, surprising study results garnered significant reader interest, as new data show that revision rates are similar in conventional and robotic-assisted cementless total knee arthroplasty at two years post-operatively. The study—based on American Joint Replacement Registry information—also found the odds of revision due to infection or mechanical loosening were not significantly different between the two methods. "Some patients desire a robotic-assisted TKA because they’ve heard it is better, but we’ve shown that there isn’t a true benefit in terms of the likelihood of needing another surgery in the early period,” said Lucas E. Nikkel, M.D., assistant professor of orthopedic surgery at Johns Hopkins Medicine.
Non-robotic surgical news drove considerable website traffic, too. BellaSeno enticed cybervisitors by sharing its customized, resorbable bone replacement scaffold was used with an autologous bone graft in trauma surgery, while Stryker marked the first shoulder arthroplasty surgeries in Europe using its Blueprint Mixed Reality (MxR) Guidance System. Designed in collaboration with surgeons, the Blueprint Mixed Reality Guidance System combines Stryker's software with the Microsoft HoloLens 2 headset, allowing surgeons to track instruments' position and orientation in the physical environment.
Other pageview triggers came from Nalu Medical, which closed an equity financing round, and Medtronic, which earned FDA 510(k) clearance for its OsteoCool 2.0 bone tumor ablation system to treat painful bone metastases and benign bone tumors. The new design allows the use of four internally cooled probes at the same time so two vertebral bodies can be ablated at once, or to create larger ablation zones in non-spinal applications.
Not surprising, since the technology is a key growth strategy among top orthopedic implant manufacturers. However, surprising study results garnered significant reader interest, as new data show that revision rates are similar in conventional and robotic-assisted cementless total knee arthroplasty at two years post-operatively. The study—based on American Joint Replacement Registry information—also found the odds of revision due to infection or mechanical loosening were not significantly different between the two methods. "Some patients desire a robotic-assisted TKA because they’ve heard it is better, but we’ve shown that there isn’t a true benefit in terms of the likelihood of needing another surgery in the early period,” said Lucas E. Nikkel, M.D., assistant professor of orthopedic surgery at Johns Hopkins Medicine.
Non-robotic surgical news drove considerable website traffic, too. BellaSeno enticed cybervisitors by sharing its customized, resorbable bone replacement scaffold was used with an autologous bone graft in trauma surgery, while Stryker marked the first shoulder arthroplasty surgeries in Europe using its Blueprint Mixed Reality (MxR) Guidance System. Designed in collaboration with surgeons, the Blueprint Mixed Reality Guidance System combines Stryker's software with the Microsoft HoloLens 2 headset, allowing surgeons to track instruments' position and orientation in the physical environment.
Other pageview triggers came from Nalu Medical, which closed an equity financing round, and Medtronic, which earned FDA 510(k) clearance for its OsteoCool 2.0 bone tumor ablation system to treat painful bone metastases and benign bone tumors. The new design allows the use of four internally cooled probes at the same time so two vertebral bodies can be ablated at once, or to create larger ablation zones in non-spinal applications.